Ensysce Biosciences, Inc.
ENSC
$2.08
$0.020.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 112.00% | -10.33% | 211.69% | 183.64% | -72.76% |
| Total Receivables | 437.47% | -77.13% | 27.15% | 1,555.34% | 108.36% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -4.30% | -16.04% | -30.38% | -18.50% | -19.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 115.66% | 24.62% | 145.80% | 350.62% | -49.18% |
| Total Current Assets | 114.73% | -6.29% | 133.51% | 229.63% | -57.99% |
|
|
|||||
| Total Current Assets | 114.73% | -6.29% | 133.51% | 229.63% | -57.99% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.80% | -44.15% | -39.74% | -36.17% | -33.17% |
| Total Assets | 99.40% | -9.11% | 106.68% | 191.57% | -56.03% |
|
|
|||||
| Total Accounts Payable | 116.35% | -37.32% | -29.90% | 114.71% | -62.18% |
| Total Accrued Expenses | 182.47% | 117.56% | 1.14% | -41.22% | -52.89% |
| Short-term Debt | -6.60% | 4.63% | -64.70% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 92.33% | 7.65% | -33.78% | 37.99% | -48.09% |
|
|
|||||
| Total Current Liabilities | 92.33% | 7.65% | -33.78% | 37.99% | -48.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -6.60% | 4.63% | -64.70% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -89.58% | 648.28% | -61.74% | -89.51% | -79.87% |
| Total Liabilities | 91.00% | 14.38% | -34.00% | 36.10% | -48.68% |
|
|
|||||
| Common Stock & APIC | 6.35% | 4.76% | 9.91% | 11.17% | 7.51% |
| Retained Earnings | -5.20% | -5.47% | -6.57% | -6.71% | -9.78% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 87.46% | -18.67% | 1,248.47% | 365.17% | -56.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 87.46% | -18.67% | 1,248.47% | 365.17% | -56.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -0.03% | 0.00% | -0.03% | -0.34% | -0.71% |
| Total Equity | 106.87% | -20.47% | 618.95% | 468.34% | -60.99% |
|
|
|||||